Business Description

Cryofocus Medtech (Shanghai) Co Ltd
Description
Cryofocus Medtech (Shanghai) Co Ltd a medical device company in China with a main focus on the field of minimally-invasive interventional cryotherapy. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for closure of soft tissue in digestive tract, which is one of over-the-scope clips. The company has developed a comprehensive product portfolio mainly focusing on two therapeutic areas: natural orifice transluminal endoscopic surgery, or NOTES; and vascular interventional therapy.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.54 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | N/A/9 |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.56 | |||||
9-Day RSI | 74.16 | |||||
14-Day RSI | 70.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.69 | |||||
Quick Ratio | 6.28 | |||||
Cash Ratio | 5.58 | |||||
Days Inventory | 518.24 | |||||
Days Payable | 13.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.32 | |||||
Operating Margin % | -553.38 | |||||
Net Margin % | -454.26 | |||||
ROE % | -92.9 | |||||
ROA % | -67.09 | |||||
ROIC % | -214.56 | |||||
ROC (Joel Greenblatt) % | -398.82 | |||||
ROCE % | -99.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 165.39 | |||||
PB Ratio | 21.76 | |||||
Price-to-Tangible-Book | 21.86 | |||||
EV-to-EBIT | -28.83 | |||||
EV-to-EBITDA | -29.89 | |||||
EV-to-Revenue | 162.14 | |||||
EV-to-FCF | -48.49 | |||||
Price-to-Net-Current-Asset-Value | 28.82 | |||||
Price-to-Net-Cash | 38.04 | |||||
Earnings Yield (Greenblatt) % | -3.47 |
How Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Cryofocus Medtech (Shanghai) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 27.46 | ||
EPS (TTM) (HK$) | -0.522 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 70.11 | ||
14-Day ATR (HK$) | 0.178179 | ||
20-Day SMA (HK$) | 18.657 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (HK$) | 13 - 19.04 | ||
Shares Outstanding (Mil) | 239.11 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cryofocus Medtech (Shanghai) Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
Cryofocus Medtech (Shanghai) Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Cryofocus Medtech (Shanghai) Co Ltd Frequently Asked Questions
What is Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922)'s stock price today?
The current price of HKSE:06922 is HK$19.02. The 52 week high of HKSE:06922 is HK$19.04 and 52 week low is HK$13.00.
When is next earnings date of Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922)?
The next earnings date of Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) is .
Does Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) pay dividends? If so, how much?
Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |